Kodiak Venture Partners led the round and was joined by Catalyst Health Ventures and Boston University. In conjunction with the financing, Andrey Zarur, general partner with Kodiak Venture Partners, and Josh Phillips, general partner with Catalyst Health Ventures, joined the company’s board of directors.
Dan Rippy, president and CEO of Allegro, said: “The series A financing will enable us to take our first product, based on intellectual property developed at the Boston University School of Medicine, into the clinic to provide earlier, more accurate diagnosis of suspected lung cancer for patients and their doctors.”